South Africa vs Switzerland: Treatment success rate for patients treated for MDR-TB
South Africa
63.0%
in 2022
Switzerland
60.0%
in 2022
South Africa rank
118th
Switzerland rank
120th
Treatment success rate for patients treated for MDR-TB over time
- South Africa
- Switzerland
How they compare
South Africa currently reports 63.0% against 60.0% in Switzerland, a difference of 3.0%.
That makes South Africa's figure about 1.1 times Switzerland's.
The two have swapped places 3 times across 9 shared years of data; in 2014 it was Switzerland ahead.
South Africa ranks 118th and Switzerland ranks 120th of 163 countries.
Across the 2 decades both report, South Africa averaged higher in 1 and Switzerland in 1.
Head to head by decade
| Decade | South Africa | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 59.0% | 68.0% | 9.0% | Switzerland |
| 2020s | 62.3% | 53.3% | 9.0% | South Africa |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, South Africa or Switzerland?
- South Africa, at 63.0% against 60.0% in Switzerland as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between South Africa and Switzerland?
- 3.0%, with South Africa ahead.
- How many years of comparable data are there for South Africa and Switzerland?
- 9 years are reported by both, from 2014 to 2022.
- How do South Africa and Switzerland rank globally for treatment success rate for patients treated for mdr-tb?
- South Africa ranks 118th and Switzerland ranks 120th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.